Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LICC: L-BLP25 in Patients with Colorectal Carcinoma after Curative Resection of Hepatic Metastases
2011-000218-20Phase 2Completed
- Sponsor
- University Medical Center Mainz
- Start
- May 2011
- Modality
- Vaccines & Immunotherapeutics, Peptides, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in colorectal cancer (CRC) comparing L-BLP25 plus cyclophosphamide with Placebo vaccination plus saline infusion (2 arms). Primary endpoints: Recurrence-Free Survival and Three-year Overall Survival. Started May 2011; status: completed.
02
Drugs
tecemotide
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2011-000218-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000218-20.